You are here

SECONDARY BENEFITS OF ANTIHYPERTENSIVE MEDICATIONS IN THE TREATMENT OF CANCER

Download pdf | Full Screen View

Date Issued:
2019-12-16
Summary:
Introduction: Traditional cancer treatments remain woefully inadequate to address and manage the increasingly complex manifestations of the disease and its insidious sequelae. While chemotherapy and surgical procedures might still be mainstays of cancer treatment, novel therapies based on existing medications should be explored if these show promise to improve cancer progression. The class of drugs that inhibit the renin-angiotensin-aldosterone-system have shown promise to stem the proliferation of malignant cells and their resulting neoplasms. Methods: Using the PubMed database, a keyword search, using terms related to the topic, produced several articles that presented studies related to the potential secondary benefits of antihypertensive drugs on cancer cell proliferation. Results: Five articles presented compelling evidence that the different types of hypertension medications could confer protection against multiplying cancer cells. Only one article mentioned the possible cancer promoting effects of such medications, but this was only in the context of treating hypertensive geriatric patients and their other age-related disorders. Conclusion: Antihypertensive drugs, particularly those that inhibit the angiotensin converting enzymes, have shown promise to shunt normal cancer metabolic pathways and shut down key processes necessary for malignant cell proliferation. Based on this research, these drugs present promise for adjuvant cancer treatment and disease management.
Title: SECONDARY BENEFITS OF ANTIHYPERTENSIVE MEDICATIONS IN THE TREATMENT OF CANCER.
4 views
0 downloads
Name(s): Szczygiel, Stacy, Author
Marieb College of Health & Human Services, Degree granting institution
Type of Resource: text
Genre: Research Project
Issuance: single unit
Date Issued: 2019-12-16
Extent: 14 pgs.
Language(s): English
Summary: Introduction: Traditional cancer treatments remain woefully inadequate to address and manage the increasingly complex manifestations of the disease and its insidious sequelae. While chemotherapy and surgical procedures might still be mainstays of cancer treatment, novel therapies based on existing medications should be explored if these show promise to improve cancer progression. The class of drugs that inhibit the renin-angiotensin-aldosterone-system have shown promise to stem the proliferation of malignant cells and their resulting neoplasms. Methods: Using the PubMed database, a keyword search, using terms related to the topic, produced several articles that presented studies related to the potential secondary benefits of antihypertensive drugs on cancer cell proliferation. Results: Five articles presented compelling evidence that the different types of hypertension medications could confer protection against multiplying cancer cells. Only one article mentioned the possible cancer promoting effects of such medications, but this was only in the context of treating hypertensive geriatric patients and their other age-related disorders. Conclusion: Antihypertensive drugs, particularly those that inhibit the angiotensin converting enzymes, have shown promise to shunt normal cancer metabolic pathways and shut down key processes necessary for malignant cell proliferation. Based on this research, these drugs present promise for adjuvant cancer treatment and disease management.
Identifier: fgcu_ETD_0319 (IID)
Degree Awarded: Master of Science
Department: Health Sciences
Committee Chair: Nelson A. Guzman, Ph. D.
Subject(s): Cancer
Medical care
Persistent Link to This Record: http://purl.flvc.org/fgcu/fd/fgcu_ETD_0319
Use and Reproduction: Creator(s) holds copyright.
Use and Reproduction: http://rightsstatements.org/vocab/InC/1.0/
Host Institution: FGCU